1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Ms C Thomas |
b) |
Position/status |
SVP, Human Resources |
c) |
Initial notification/ amendment |
Initial Notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
b) |
Nature of the transaction |
The exercise of a nil-cost option over Ordinary Shares granted on 20 March 2014 and, as previously announced, was adjusted for performance and vested on 20 March 2017 under the Company's 2009 Deferred Annual Bonus Plan- Matching Award associated with a post-tax bonus deferral. |
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
£0.0000 |
989 |
|
|
|
|
|
d) |
Aggregated information |
n/a single transaction |
Aggregated volume Price |
|
e) |
Date of the transaction |
2017-04-28 |
f) |
Place of the transaction |
n/a |